IMMUNOVANT INC. - COMMON STOCK
14,02
09-мая-25 16:45:00
15 мин. задержка
Акции
-0,28
-1,96%
Сегодняшний диапазон
14,00 - 14,71
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
21 апр 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
19 мар 2025 07:45:00 Источник Nasdaq GlobeNewswire
-
18 мар 2025 16:32:00 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter Ended December 31, 2024
06 фев 2025 06:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant Announces $450 Million Private Placement
13 янв 2025 08:00:01 Источник Nasdaq GlobeNewswire
-
07 ноя 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
29 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant Provides Update on Graves’ Disease Development Program
09 сен 2024 03:55:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Host Graves’ Disease Program Update on September 9, 2024
05 сен 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
06 авг 2024 16:05:01 Источник Nasdaq GlobeNewswire
-
29 май 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Immunovant Awarded U.S. Patent for IMVT-1402
12 мар 2024 07:30:04 Источник Nasdaq GlobeNewswire
-
12 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
20 дек 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
28 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at Upcoming Investor Conferences
13 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
09 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
02 окт 2023 16:52:02 Источник Nasdaq GlobeNewswire
-
Immunovant Announces Pricing of $450 Million Common Stock Financing
27 сен 2023 23:41:51 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >